Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:09:00 AM
From: arpad toth	Read Replies (2) \| Respond to of 122087

TONY! Is AOL a buy at 60?? Thanks,Arpad

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:17:00 AM
From: exflack	Respond to of 122087

Anthony - do you still like ESHR? thanks

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:45:00 AM
From: TripleT	Read Replies (1) \| Respond to of 122087

Anthony, no one can say for certain. However, I've served on government review boards before and can say that they like to have all their questions answered and can be very obstinate if the applicant balks. The FDA panel rejected the SNRS data because of two reasons 1. The test results are really dismal if you look at some of the statistics. The regression is just a company smokescreen to cover up the fact that the doctors set out for "some improvement" vrs "correct the eyesight". Hence the slide that stated "properly managed expectation". Believe it or not, it was there on the SNRS website. It as well as all the potentially damaging pages were removed by the company. 2. The company did not provide the test data as requested by the panel. I'm not currently short the stock. Any tips on how to play this thing if the application fails? Shorting is going to impossible Friday morning and I've read that the stock will be stopped Thursday because of the review. Thanks in advance TTT

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:53:00 AM
From: Yak-attack	Respond to of 122087

I think there lasers will be approved to do laser eye surgery on goats.

To: Anthony@Pacific who wrote (49426)	1/12/2000 11:55:00 AM
From: Kevin Podsiadlik	Read Replies (1) \| Respond to of 122087

I may be wrong on this, but it's my understanding SNRS's current application is for a lower standard of approval than they had in July; specifically they will ask for approval for temporary improvement only. If that is correct, then SNRS could conceivably get approval and still tank the stock. (See for example BTX [nee BTIM]).

To: Anthony@Pacific who wrote (49426)	1/12/2000 12:19:00 PM
From: majormember	Read Replies (2) \| Respond to of 122087

SNRS vote- Yes on approval. Reasons: 1. Lehman put "Buy" rating Dec. 13th 2. Lehman pumps 11.7 Mil on Jan. 11th 3. The two most antaganistic panel members won't be on this panel. 4. My M.D., Eve H., voting panel member, wouldn't tell me her vote (of course). I surmised it would be yes. 5. Hopkins/Wilmer is sending Dr. Stark as a non-voting panel member. He is a Big Gun and pro-SNRS. 6. Ultimately, the bar for approval has been lowered and the FDA who scheduled this would not want a rejection. "that-that's about all folks" (bugs bunny)